Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Performer
996.4000 6.55 (0.66%)
NSE Sep 11, 2025 15:31 PM
Volume: 265.0K
 

996.40
0.66%
Geojit BNP Paribas
We downgrade our rating from Buy to Accumulate, based on 22x FY22E EPS with a target price of Rs.746 as the recent rally has factored in the positive triggers for the company . SPL's Q1FY21 revenue grew by 21% YoY to Rs.238cr led by growth...
Cohance Lifesciences.. has an average target of 1346.50 from 2 brokers.
More from Cohance Lifesciences Ltd.
Recommended